Colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix

Colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest paper, Sep 15, 2026: “A self-crosslinkable, adhesive intestine-derived extracellular matrix hydrogel enhances organoid retention and restores intestinal barrier integrity”.

Intervention

1 paper studies it1 findingUpdated

See all 1 papers on colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funders: Korea Research Institute of Bioscience & Biotechnology and 3 more
  • 1 of 1 finding with company ties
  • Animals1

What did studies of colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix find?

1

Studies of colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix measured one outcome, intestinal barrier integrity.

Intestinal barrier integrity

upin mice1

1 study
  1. Colonic organoids + pyrogallol-conjugated intestine-derived extracellular matrix improves intestinal barrier integrity in mice (mouse colonic ulcer model).

    “demonstrated effective cell retention in the intestinal tract, thereby restoring the structural integrity and function of the intestinal barrier.”

    Animalsmouse colonic ulcer model

    A self-crosslinkable, adhesive intestine-derived extracellular matrix hydrogel enhances organoid retention and restores intestinal barrier integrity

    Bioactive materials

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months